Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi (IST:MEDTR)

IST:MEDTR Statistics

Total Valuation

IST:MEDTR has a market cap or net worth of TRY 3.80 billion. The enterprise value is 3.43 billion.

Market Cap	3.80B
Enterprise Value	3.43B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	Oct 27, 2025

Share Statistics

IST:MEDTR has 119.00 million shares outstanding.

Current Share Class	95.38M
Shares Outstanding	119.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	79.41%
Owned by Institutions (%)	4.49%
Float	24.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.72
PB Ratio	1.50
P/TBV Ratio	1.51
P/FCF Ratio	11.37
P/OCF Ratio	7.69
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.26, with an EV/FCF ratio of 10.25.

EV / Earnings	-47.35
EV / Sales	1.55
EV / EBITDA	16.26
EV / EBIT	36.09
EV / FCF	10.25

Financial Position

The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.02.

Current Ratio	3.57
Quick Ratio	1.98
Debt / Equity	0.02
Debt / EBITDA	0.21
Debt / FCF	0.15
Interest Coverage	2.41

Financial Efficiency

Return on equity (ROE) is -3.55% and return on invested capital (ROIC) is 3.33%.

Return on Equity (ROE)	-3.55%
Return on Assets (ROA)	2.70%
Return on Invested Capital (ROIC)	3.33%
Return on Capital Employed (ROCE)	4.48%
Revenue Per Employee	2.89M
Profits Per Employee	-94,658
Employee Count	765
Asset Turnover	0.79
Inventory Turnover	2.68

Taxes

In the past 12 months, IST:MEDTR has paid 72.37 million in taxes.

Income Tax	72.37M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.87% in the last 52 weeks. The beta is 0.42, so IST:MEDTR's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	-22.87%
50-Day Moving Average	32.65
200-Day Moving Average	37.04
Relative Strength Index (RSI)	53.16
Average Volume (20 Days)	1,506,007

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IST:MEDTR had revenue of TRY 2.21 billion and -72.41 million in losses. Loss per share was -0.61.

Revenue	2.21B
Gross Profit	712.23M
Operating Income	120.91M
Pretax Income	-6.12M
Net Income	-72.41M
EBITDA	235.53M
EBIT	120.91M
Loss Per Share	-0.61

Balance Sheet

The company has 426.89 million in cash and 50.30 million in debt, giving a net cash position of 376.58 million or 3.16 per share.

Cash & Cash Equivalents	426.89M
Total Debt	50.30M
Net Cash	376.58M
Net Cash Per Share	3.16
Equity (Book Value)	2.53B
Book Value Per Share	21.27
Working Capital	1.29B

Cash Flow

In the last 12 months, operating cash flow was 494.38 million and capital expenditures -160.02 million, giving a free cash flow of 334.36 million.

Operating Cash Flow	494.38M
Capital Expenditures	-160.02M
Free Cash Flow	334.36M
FCF Per Share	2.81

Margins

Gross margin is 32.19%, with operating and profit margins of 5.46% and -3.27%.

Gross Margin	32.19%
Operating Margin	5.46%
Pretax Margin	-0.28%
Profit Margin	-3.27%
EBITDA Margin	10.64%
EBIT Margin	5.46%
FCF Margin	15.11%

Dividends & Yields

This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 0.92%.

Dividend Per Share	0.29
Dividend Yield	0.92%
Dividend Growth (YoY)	-42.86%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	0.92%
Earnings Yield	-1.90%
FCF Yield	8.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 22, 2022. It was a forward split with a ratio of 3.5.

Last Split Date	Feb 22, 2022
Split Type	Forward
Split Ratio	3.5

Scores

IST:MEDTR has an Altman Z-Score of 6 and a Piotroski F-Score of 4.

Altman Z-Score	6
Piotroski F-Score	4